Literature DB >> 17447343

Anti-diabetic activity of Aloe excelsa.

M Gundidza1, S Masuku, G Humphrey, M L Magwa.   

Abstract

OBJECTIVE: To investigate the effect of Aloe excelsa powder on diabetes.
DESIGN: The experiment was carried out in the laboratory on both normal and diabetic rats. Diabetes was induced in the rats by using streptozotocin. Thereafter, blood samples were taken from both the normal and diabetic rats and the sugar levels measured by using the Accutrend Alpha blood glucose monitoring kit.
SETTING: The experiment was conducted in the laboratory in the Faculty of Medicine at the University of Zimbabwe.
SUBJECTS: A total of 280 male albino rats weighing 250 g on average were used. They were obtained from the Animal House of the Medical School at the University of Zimbabwe. MAIN OUTCOME MEASURES: Reduction in sugar levels.
RESULTS: The Aloe excelsa powder produced a dose-dependent reduction in the blood glucose in blood glucose levels. It also compared well with the effect of insulin.
CONCLUSION: This study shows that Aloe excelsa has significant activity on glucose levels in rats and this, therefore, confirms the claims by traditional healers that this plant has anti-diabetic effects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 17447343

Source DB:  PubMed          Journal:  Cent Afr J Med        ISSN: 0008-9176


  3 in total

1.  Possible hypoglycemic effect of Aloe vera L. high molecular weight fractions on type 2 diabetic patients.

Authors:  Akira Yagi; Sahar Hegazy; Amal Kabbash; Engy Abd-El Wahab
Journal:  Saudi Pharm J       Date:  2009-08-07       Impact factor: 4.330

2.  Antidiabetic and Antihyperlipidemic Activities of the Leaf Latex Extract of Aloe megalacantha Baker (Aloaceae) in Streptozotocin-Induced Diabetic Model.

Authors:  Workineh Woldeselassie Hammeso; Yohannes Kelifa Emiru; Kefyalew Ayalew Getahun; Wubayehu Kahaliw
Journal:  Evid Based Complement Alternat Med       Date:  2019-04-23       Impact factor: 2.629

3.  In vitro α-amylase inhibitory effect of TLC isolates of Aloe megalacantha baker and Aloe monticola Reynolds.

Authors:  Gebretsadkan Hintsa Tekulu; Ephrem Mebrahtu Araya; Hayelom Gebrekirstos Mengesha
Journal:  BMC Complement Altern Med       Date:  2019-08-07       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.